Phase 2 Stage III Non-small Cell Lung Cancer trials recruiting now

All Stage III Non-small Cell Lung Cancer trials, every phase

Phase 2 Stage III Non-small Cell Lung Cancer trials

• A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
  NCT05361174 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 11 locations
• PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
  NCT06102057 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 11 locations
• PALACE: Cemiplimab Trial According to ctDNA Levels
  NCT06917573 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations
• Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy
  NCT05468242 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.